COMMUNIQUÉS West-GlobeNewswire

Compass Pathways to participate in upcoming H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
24/06/2024
LONDON, June 24, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that [...]
Avalo Therapeutics Announces Appointment of Paul Varki as Chief Legal Officer
24/06/2024
WAYNE, Pa. and ROCKVILLE, Md., June 24, 2024 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) today announced that Paul Varki has joined the Company as its Chief Legal Officer. “We are delighted to have Paul [...]
Ultimovacs ASA announces revised terms of the employee share option program
24/06/2024
Oslo, June 24, 2024: Ultimovacs ASA (“Ultimovacs”) (OSE ULTI), a clinical-stage biotechnology company developing immunotherapeutic cancer vaccines, announces revised terms of the employee share option program. [...]
Novo Nordisk announces 4.1 billion USD investment to expand US manufacturing capacity adline
24/06/2024
In 2024, Novo Nordisk plans to boost its current investments, aiming to allocate USD 6.8 billion towards production, a significant increase from the previous year's investment of USD 3.9 billion*. Bagsværd, Denmark, 24 [...]
Tecan appoints Mukta Acharya Head of the Life Sciences Business division
24/06/2024
Tecan appoints Mukta Acharya Head of the Life Sciences Business division Männedorf, Switzerland, June 24, 2024 – The Tecan Group (SIX Swiss Exchange: TECN) announced today that Mukta Acharya, currently serving as [...]
Le KFSH&RC produit avec succès les premiers lymphocytes T thérapeutiques du royaume
24/06/2024
Réduction des coûts de traitement d’environ 80 % et accès accéléré au traitement RIYADH, Arabie saoudite, 24 juin 2024 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital & Research Centre (« KFSH&RC ») a [...]
Medigene Reports Results of Annual General Meeting
24/06/2024
Shareholders approve all proposed resolutions Re-election of two members of the Supervisory Board Reduction of share capital by consolidation of shares at a ratio of 2:1 approved Creation of new authorized capital [...]
LUKE Welcomes William Grubbs to Board of Directors
24/06/2024
ROCKLEDGE, Fla., June 24, 2024 (GLOBE NEWSWIRE) -- LUKE Holdings, Inc. (“LUKE”), a trusted leader in healthcare staffing for the U.S. Government, announced the addition of William J. Grubbs to the LUKE Board of [...]
Transactions in Connection with Share Buy-back Program
24/06/2024
Company Announcement COPENHAGEN, Denmark; June 24, 2024 – Genmab A/S (Nasdaq: GMAB). On March 15, 2024, Genmab announced the initiation of a share buy-back program to repurchase up to DKK 3.5 billion worth of shares. [...]
SOPHiA GENETICS Publishes Results of 2024 Annual General Meeting
24/06/2024
Shareholders adopt all proposals at Annual General Meeting BOSTON and ROLLE, Switzerland, June 24, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a healthcare technology company and a leader in data-driven [...]
SELLAS Announces U.S. FDA Rare Pediatric Disease Designation Granted to SLS009 for the Treatment of Pediatric Acute Lymphoblastic Leukemia
24/06/2024
- Acute Lymphoblastic Leukemia (ALL) is the Most Common Type of Cancer in Children – - Rare Pediatric Disease Designation (RPDD) Provides Eligibility for SLS009 to Receive a Priority Review Voucher (PRV) Upon Marketing [...]
Palisade Bio to Participate in the Virtual Investor Closing Bell Series
24/06/2024
Live video webcast on Wednesday, June 26 th at 4:00 PM ET Carlsbad, CA, June 24, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), biopharmaceutical company focused on developing [...]
BayMark Health Services Announces Leadership Transition: David White Steps Down as CEO; Marshal Salomon Named Successor
24/06/2024
LEWISVILLE, Texas, June 24, 2024 (GLOBE NEWSWIRE) -- BayMark Health Services announces that, after a long and successful career in the behavioral health and addiction field, David K. White, PhD, is stepping down from [...]
Shineco, Inc. Announces Entering into a Securities Purchase Agreement with Gross Proceeds of $7.0 Million
24/06/2024
BEIJING, June 24, 2024 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a provider of innovative diagnostic medical products and related medical devices, announced today that on June 20, [...]
Novo Nordisk A/S - share repurchase programme
24/06/2024
Bagsværd, Denmark, 24 June 2024 – On 6 May 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) [...]
Biodexa Announces Positive Phase 2 Clinical Trial Results of eRapa™ at 12 months in Familial Adenomatous Polyposis (FAP)
24/06/2024
June 24, 2024 Biodexa Pharmaceuticals PLC Biodexa Announces Positive Phase 2 Clinical Trial Results of eRapa™ at 12 months in Familial Adenomatous Polyposis (FAP) Overall 75% Non-progression Rate at 12 Months Median [...]
Matinas BioPharma Reports Successful Treatment of Patient with Limb-Threatening Mucor Infection in its Oral MAT2203 Compassionate/Expanded Use Access Program
24/06/2024
BEDMINSTER, N.J., June 24, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies using its lipid [...]
Veru Announces Safety and Body Composition Data from Two Late-Breaker Presentations at the American Diabetes Association's 84th Scientific Sessions
24/06/2024
MIAMI, FL, June 24, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, [...]
Creative Medical Technology Holdings Announces Evolutionary Development of its iPSCelz® Program with the Successful Generation of iPSC Derived Islet Cells that Produce Human Insulin
24/06/2024
PHOENIX, June 24, 2024 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (“Creative Medical Technology” or the “Company”) (NASDAQ: CELZ), a leading commercial stage biotechnology company focused on a [...]

Pages